Nursing home recognized for dramatic reduction in physical restraint use
Jul 26, 2011
A New Jersey nursing facility was recently honored for dramatically reducing physical restraint use among its residents.
To group, or not to group
By
Shelly Mesure, MS, OTR/L
Jul 25, 2011
By simply creating more confusion, the Centers for Medicare & Medicaid Services has made it more difficult for providers. In turn, providers are still expected to be ready to provide the best treatment...
KCI to be bought for $5 billion
Jul 20, 2011
Kinetic Concepts Inc. has agreed to a $5 billion cash buyout from a consortium that includes Apax Partners and two leading Canadian pension funds. KCI makes medical devices and other wound care products....
Zenith 9000 bed is now available
Jul 20, 2011
Basic American Medical Products, a division of GF Health Products Inc., has unveiled its Zenith 9000 Long Term Care Bed. The bed is designed and manufactured in the United States. Features include a seven...
Top therapy reimbursement for everyone: here’s how
By
Shelly Mesure, MS, OTR/L
Jul 18, 2011
If the Ultra High is the highest level of allowable treatment we may seek, it’s our professional obligation to clinically provide these levels of service to every patient.
HCS Software announces HIPAA 5010 approval for Interactant
Jul 12, 2011
Health Care Software Inc. (HCS) announced that its Interactant software product is 5010 certified to meet the upcoming mandates issued by the government to move from HIPAA 4010 to HIPAA 5010 by Jan. 1,...
White House, Baucus, support ‘blended’ Medicaid payments
Jul 08, 2011
Senate Finance Committee Chairman Max Baucus (D-MT) said Wednesday that a proposal to implement “blended” payment rates for Medicaid is “on the table” in negotiations over raising...
New antimicrobial technology renders textiles, surfaces germ-free
Jul 07, 2011
A University of Georgia researcher says he has invented an antimicrobial technology that can make any material, either natural or synthetic, permanently germ-free.
FDA approves medicine for treatment of deep vein thrombosis
Jul 06, 2011
The Food and Drug Administration has approved Janssen Pharmaceuticals, Inc.’s Xarelto (rivaroxaban ). Xarelto is intended for the treatment of deep vein thrombosis (DVT). If all or part of a DVT...
Court upholds big damages award to Ventas in HCP case
By
Elizabeth Newman
Jul 01, 2011
Ventas has once again won a legal victory, with a federal appeals court upholding a $101.6 million damages award in its favor against HCP Inc.